An antinuclear antibody (ANA) positivity can be observed in >80% of cases and extractable nuclear antigen (ENA) antibodies in SS patients directed against Ro/SSA and La/SSB antigens can be observed in 33–74% and 23–52% of cases, respectively [8]. Here, CALR is linked to synovial sarcoma.